Announcements Trials
Browse Landscape

Phase

Phase 1 49Phase 1/2 20Phase 2 15Phase NA 4Phase 3 2Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 8Thoracic 1Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 26Uterine Cervical Neoplasms 16Endometrial Neoplasms 14Fallopian Tube Neoplasms 10Carcinoma, Ovarian Epithelial 7Colorectal Neoplasms 6Peritoneal Neoplasms 5Neoplasms 5Uterine Cervical Dysplasia 4Lung Neoplasms 4Gestational Trophoblastic Disease 4Pancreatic Neoplasms 3Neoplasms by Site 3Neoplasms by Histologic Type 3Melanoma 3Hematologic Neoplasms 3Endometrial Hyperplasia 3Urinary Bladder Neoplasms 2Thyroid Carcinoma, Anaplastic 2Thyroid Cancer, Papillary 2Stomach Neoplasms 2Prostatic Neoplasms 2Progesterone Resistance 2Ovarian Cysts 2Obesity 2Multiple Myeloma 2Lymphoproliferative Disorders 2Laryngeal Neoplasms 2Head and Neck Neoplasms 2Glioma 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Carcinoma, Transitional Cell × Gynecologic × Clear all
NCT06851663 2026-05-29

Trop2-targeted immunoPET Imaging of Solid Tumors

RenJi Hospital

Phase 2/3 Recruiting
400 enrolled
GastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Nasopharyngeal Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡